• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Brain+

Less than 1K followers
Overview
Ownership
Investor consensus
All
Press releases
3rd party
ShowingAll content types

Regulatory press release23.03.2026 klo 14.36

Bankruptcy order issued for BRAIN+ A/S

Brain+
Regulatory press release19.03.2026 klo 14.59

BRAIN+ A/S to file for bankruptcy - 19 March 2026

Brain+
Regulatory press release12.03.2026 klo 16.12

Update on in-court restructuring proceedings - 12 March 2026

Brain+

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release05.03.2026 klo 14.20

Update on in-court restructuring proceedings - 5 March 2026

Brain+
Regulatory press release13.02.2026 klo 17.34

Update on in-court restructuring proceedings - 13 February 2026

Brain+
Regulatory press release04.02.2026 klo 18.36

Update on in-court restructuring proceedings - 4 February 2026

Brain+
Regulatory press release27.01.2026 klo 14.34

Correction: Update on in-court restructuring proceedings - 27 January 2026

Brain+
Regulatory press release27.01.2026 klo 14.10

Update on in-court restructuring proceedings - 27 January 2026

Brain+
Regulatory press release20.01.2026 klo 21.52

Notice of in-court restructuring proceedings of BRAIN+ A/S

Brain+
Regulatory press release20.01.2026 klo 11.07

Brain+ is seeking restructuring proceedings

Brain+
Press release08.01.2026 klo 23.29

Brain+ Investor Update – December 2025

Brain+
Press release04.12.2025 klo 13.46

Brain+ Investor Update - November

Brain+
Regulatory press release19.11.2025 klo 13.24

Brain+ A/S updates its financial guidance for 2025

Brain+
Press release06.11.2025 klo 16.13

Brain+ investor update — October

Brain+
Press release31.10.2025 klo 09.00

BRAIN+ UPDATES ITS COMMUNICATION POLICY AS THE COMPANY MOVES INTO A NEW COMMERCIALISATION PHASE

Brain+
Regulatory press release06.10.2025 klo 09.20

Brain+ appoints new Chief Financial Officer

Brain+
Press release24.09.2025 klo 09.36

Brain+ launches first Ayla NHS pilot with one of the UK’s largest primary care practices

Brain+
Press release16.09.2025 klo 10.21

Brain+ signs agreement with Agincare Homes – the fourth UK care home group to deploy effective dementia therapy with Ayla

Brain+
Regulatory press release15.09.2025 klo 12.41

The Chief Financial Officer to transition, replacement search has been initiated

Brain+
Press release04.09.2025 klo 12.58

Clinical pilot of Ayla based dementia therapy (CST) improves cognitive outcome by nearly 50% in care home residents

Brain+